| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/09/2026 | ±3.0% | +0.0% | over-priced |
| 07/10/2026 | ±4.0% | -1.8% | over-priced |
| 04/08/2026 | ±4.0% | +3.8% | over-priced |
| 02/11/2026 | ±3.6% | -4.1% | under-priced |
| 10/09/2025 | ±2.8% | +4.3% | under-priced |
| 07/10/2025 | ±3.6% | +12.0% | under-priced |
| 04/09/2025 | ±10.8% | +23.4% | under-priced |
| 02/11/2025 | ±3.0% | -2.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $1.15 | $20.2B | $756M |
| Q2 FY2026 | $2.44 | $19.8B | $1.6B |
| Q1 FY2026 | $-0.44 | $15.9B | $-289M |
| Q4 FY2025 | — | $16.0B | $1.2B |
DAL (DAL) reports in 73 days, with the next report estimated for 01/08/2027. Across the last 8 reports, options priced an average ±4.3% earnings move while the stock actually moved 6.4% on average — the market has been roughly fair on DAL's earnings risk. Fundamentals into the print: EPS down 47.0% year-over-year, revenue up 21.1%. QuantLogix's live 5-factor engine currently reads DAL as a buy at 62/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →